Document is current
Any future updates will be listed below
-
Authors
-
License Information
Text and Data Mining valid from 2020-10-07
Version of Record valid from 2020-10-07
-
More Information
Article History
Received: 27 May 2020
Accepted: 4 September 2020
First Online: 7 October 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: No funding was solicited or received for this manuscript. <b>JS</b> and <b>JS</b> conduct cannabis research as university members of the Australia Medicinal Cannabis Research and Education Collaboration (ExternalRef removed). <b>J. Sarris</b> has received a consultancy payment from a cannabis manufacturing company as an independent scientific advisor (Australian Natural Therapeutics Group); this is however completely unrelated to this manuscript. He has also received either presentation honoraria, travel support, clinical trial grants, book royalties, or independent consultancy payments from: Integria Healthcare & MediHerb, Pfizer, Scius Health, Key Pharmaceuticals, Fiji Kava, Research Reviews, Taki Mai, Bioceuticals & Blackmores, Soho-Flordis, Healthworld, HealthEd, HealthMasters, Kantar Consulting, Elsevier, Chaminade University, International Society for Affective Disorders, Complementary Medicines Australia, SPRIM, Terry White Chemists, ANS, Society for Medicinal Plant and Natural Product Research, Sanofi-Aventis, Omega-3 Centre, the National Health and Medical Research Council, CR Roper Fellowship. <b>J. Sinclair</b> has sat on the Scientific Advisory Board for BioCeuticals. LS and AK declare that they have no competing interests.
